Head-to-head · WeighScore
Goldspan Health vs Strut Health
The verdict
Strut Health takes it — 79.4/100 to 68.2/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Goldspan Health | Strut Health |
|---|---|---|
| WeighScore | 68.2/100 | 79.4/100 |
| Grade | C | C+ |
| Site position | #169 | #28 |
| Semaglutide | $229 per 28 days (a single plan; thirteen charges a year) | From $99/mo sublingual, $149/mo injectable |
| Tirzepatide | $299 per 28 days (a single plan; thirteen charges a year) | From $199/mo either route |
| Coverage | All 50 states plus Washington, D.C. | 49 states (not Arkansas) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Site position #169 · C
Strengths
- One plan per molecule with no tier ladder to read, which removes the commonest source of a misquoted price
- Sublingual full-dose and microdose lines sit alongside the injections for readers who will not inject
- States its compounding class — dispensed by a pharmacy licensed under 503A or 503B — rather than leaving it unsaid
- Names a medical director and two clinical advisors by name and specialty
- A lab panel is genuinely required at 60 to 90 days and annually after that, which is stronger monitoring than most of this ranking asks for
Where it loses points
- The required lab panel is described as available at a low cost and its cost is stated nowhere on the site
- The hero says “/month”, the plan card says billed every 28 days and the order timeline says every four weeks — thirteen charges a year, not twelve
- “Pause, delay, or cancel at any time” on the storefront sits against a refund policy reading “all sales are final” and platform terms saying an order cannot be canceled once placed
- The tirzepatide sublingual microdose page lists compounded sublingual semaglutide microdose in its own inclusion list
- Clinicians are attributed to a partner platform while the storefront states it is not a medical practice
- No pharmacy is named, and Goldspan publishes no legal entity, address or governing law of its own
- Full-dose sublingual products exist on the catalog and are not linked from the site's own weight-loss page
Site position #28 · C+
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
- Every route and auto-refill saving published on the product page rather than inside an intake
- Free physician visit, free shipping and free follow-up care included
- Cancel, pause or delay yourself with 48 hours' notice
Where it loses points
- Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
- No published lab or monitoring program
- Compounded only, with no brand-name lane
- Not available in Arkansas
Featured provider
Strut Health
Strut Health scores 79.4/100 (C+). The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.